Medpace
MEDP
678 hedge funds and large institutions have $12.4B invested in Medpace in 2025 Q3 according to their latest regulatory filings, with 140 funds opening new positions, 184 increasing their positions, 275 reducing their positions, and 60 closing their positions.
133% more first-time investments, than exits
New positions opened: 140 | Existing positions closed: 60
100% more funds holding in top 10
Funds holding in top 10: 6 → 12 (+6)
12% more funds holding
Funds holding: 605 → 678 (+73)
5.67% less ownership
Funds ownership: 91.74% → 86.07% (-5.7%)
33% less repeat investments, than reductions
Existing positions increased: 184 | Existing positions reduced: 275
47% less capital inflows, than outflows
Capital inflows: $1.01B | Capital outflows: $1.92B
52% less call options, than puts
Call options by funds: $54.3M | Put options by funds: $113M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
+$176M |
| 2 |
D.E. Shaw & Co
New York
|
+$112M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$92.3M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$37.3M |
| 5 |
Goldman Sachs
New York
|
+$36.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$144M |
| 2 |
Epoch Investment Partners
New York
|
-$140M |
| 3 |
Jane Street
New York
|
-$112M |
| 4 |
Millennium Management
New York
|
-$100M |
| 5 |
Two Sigma Advisers
New York
|
-$83M |
MEDP Hedge Fund Activity: Q3 2025 in Review
678 of the 7,661 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q3 2025, worth a combined $12.4B — up 50% from $8.28B a quarter earlier.
Buyers outnumbered sellers: 140 funds opened new MEDP positions and 60 closed out — a net gain of 80 holders — while 184 added to existing stakes and 275 trimmed.
The largest buyer was AQR Capital Management, adding an estimated $176M. The largest seller was TD Asset Management, cutting an estimated $144M.
- 678 institutional investors held Medpace (MEDP) as of Q3 2025, up from 605 in Q2 2025.
- Funds reported $12.4B of Medpace stock for Q3 2025, up 50% quarter-over-quarter.
- 140 funds opened new Medpace positions in Q3 2025 and 60 closed out, a net change of +80 holders.
- The largest Medpace buyer in Q3 2025 was AQR Capital Management, an estimated $176M added.
- The largest Medpace seller in Q3 2025 was TD Asset Management, an estimated $144M sold.
Based on aggregated 13F filings for Q3 2025.